| Venipuncture | |
---|---|---|
 | A | B |
Total number of patients | 94 | 31 |
Breast cancer | Â | Â |
   Number | 21 | 31 |
   Age (yrs) |  |  |
median | 54 | 50 |
range | 35-78 | 25-75 |
   Histology |  |  |
IDC | 100.0% | 64.5% |
ILC | 0 | 12.9% |
Others/unknown | 0 | 22.6% |
   TNM Stage * |  |  |
I | 38.1% | 3.2% |
II | 33.3% | 48.4% |
III | 23.8% | 19.4% |
IV | 4.8% | 3.2% |
Unknown | 0 | 22.6% |
Endometrial cancer | Â | Â |
   Number | 25 | 0 |
   Age (yrs) |  |  |
median | 64 | Â |
range | 30-83 | Â |
   Histology |  |  |
Endometrioid | 100.0% | Â |
   FIGO Stage |  |  |
I | 60.0% | Â |
II | 8.0% | Â |
III | 28.0% | Â |
IV | 4.0% | Â |
Cervical Cancer | Â | Â |
   Number | 25 | 0 |
   Age (yrs) |  |  |
median | 48 | Â |
range | 29-78 | Â |
   Histology |  |  |
Non-keratinizing | 48.0% | Â |
Keratinizing | 40.0% | Â |
Others/unknown | 12.0% | Â |
   FIGO Stage |  |  |
I | 8.0% | Â |
II | 44.0% | Â |
III | 28.0% | Â |
IV | 20.0% | Â |
Ovarian cancer | Â | Â |
   Number | 23 | 0 |
   Age (yrs) |  |  |
median | 53 | Â |
range | 37-78 | Â |
   Histology |  |  |
Serous | 72.7% | Â |
Mucinous | 12.1% | Â |
Others/unknown | 15.1% | Â |
   FIGO Stage |  |  |
I | 10.0% | Â |
II | 10.0% | Â |
III | 65.0% | Â |
IV | 15.0% | Â |